Healios AG

About

Healios AG is a MedTech company aiming to develop and validate digital biomarkers

Basel,Basel-Stadt,Switzerland
11 - 50

Highlights

Details

Last Funding Type: Seed
Industries: Clinical Trials,Medical Device
Founded date: Jan 1, 2014
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Healios AG
Also Known As: Healios

Healios is a Medical Device Software Manufacturer that is dedicated to finding solutions in clinical research and patient monitoring through innovative digital technologies. With novel, validated and patented Digital Biomarkers, we aim at measuring – with unprecedented sensitivity – changes in motor and cognitive functions in patients with neurological disorders. These novel biomarkers will establish a new standard for both pharmacological research and clinical practice.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

8

Fr3.84M $174.68K

Healios AG has raised a total of Fr3.84M $174.68K in funding over 2 rounds. Their latest funding was raised on Aug 30, 2022 from a Seed round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 30, 2022	Seed	—	2	—	—	Detail
Dec 21, 2021	Angel	Fr1.10M	—	—	—	Detail
Aug 4, 2020	Grant	$174.68K	—	—	—	Detail
Jul 6, 2020	Convertable Note	Fr1.10M	—	—	—	Detail
Oct 10, 2019	Grant	Fr55K	—	—	—	Detail